Dihydropyrimidine dehydrogenase deficiency presenting at birth
N A Al-Sanna'a1, A B P Van Kuilenburg, T M Atrak
1Division of Pediatrics, Dhahran Health Center, Saudi Aramco, Dhahran, Saudi Arabia.
Abstract:
Dihydropyrimidine dehydrogenase (DPD) deficiency (McKusick 274270) is a clinically heterogeneous autosomal recessive disorder of pyrimidine metabolism. DPD is the enzyme that catalyses the first and the rate-limiting step in the catabolism of uracil, thymine and the analogue 5-fluorouracil. To date, more than 30 patients have been diagnosed with a complete enzyme deficiency. Here, we describe the fifth case with a complete DPD deficiency presenting at birth with severe neurological abnormalities. The patient was homozygous for the common splice-site mutation IVS14+1G > A.
Related Concept Videos
Huntington Disease l: Introduction
Pedigree Analysis
Jaundice
Diabetic Retinopathy
Type I Diabetes I: Introduction
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
